Open access
Open access
Powered by Google Translator Translator

Cardiac Surgery

Cohort Study: Effects of fluoroquinolones on outcomes of patients with aortic dissection or aneurysm

13 Apr, 2021 | 05:05h | UTC

Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm – Journal of the American College of Cardiology

Commentary: Fluoroquinolones Associated With Increased Risk of Aortic Dissection, Aneurysm – American College of Cardiology

Related: Another study suggests fluoroquinolone use may increase the risk of development of aortic aneurysms (study and commentaries) AND Link between fluoroquinolones, aorta problems may not be as strong as thought AND Study: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation AND FDA Warns About Increased Risk of Aortic Dissection and Ruptures of Aortic Aneurism with Fluoroquinolones AND Meta-analysis: Fluoroquinolones and the Risk of Aortopathy AND Study: Oral Fluoroquinolone and the Risk of Aortic Dissection AND Research: Fluoroquinolone use and risk of aortic aneurysm and dissection

 


Controversies in revascularization for stable coronary artery disease

30 Mar, 2021 | 02:49h | UTC

Controversies in revascularisation for stable coronary artery disease – Clinical Medicine Journal

 


Long-term outcomes of patients undergoing the Ross procedure

21 Mar, 2021 | 21:42h | UTC

Long-Term Outcomes of Patients Undergoing the Ross Procedure – Journal of the American College of Cardiology

Commentaries: Ross Procedure Done Well Holds Up Over Time – TCTMD AND Long-Term Outcomes of the Ross Procedure – American College of Cardiology

 


Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

23 Mar, 2021 | 02:33h | UTC

SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery – Anaesthesia

Related: Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk – Anaesthesia

 

Commentary on Twitter

 


Platelet tests pre-CABG may safely shorten washout waits, cut costs

16 Mar, 2021 | 01:44h | UTC

Platelet Tests Pre-CABG May Safely Shorten Washout Waits, Cut Costs – TCTMD

Original study: Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization – Journal of the American College of Cardiology

 


M-A: Angiographic Patency of Coronary Artery Bypass Conduits

12 Mar, 2021 | 08:10h | UTC

Angiographic Patency of Coronary Artery Bypass Conduits: A Network Meta‐Analysis of Randomized Trials – Journal of the American Heart Association

 


Prevalence of bicuspid aortic valve and associated aortopathy in newborns in Copenhagen, Denmark

21 Feb, 2021 | 21:58h | UTC

Prevalence of Bicuspid Aortic Valve and Associated Aortopathy in Newborns in Copenhagen, Denmark – JAMA (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Expert consensus of data elements for collection for enhanced recovery after cardiac surgery

21 Feb, 2021 | 21:53h | UTC

Expert Consensus of Data Elements for Collection for Enhanced Recovery After Cardiac Surgery – World Journal of Surgery

Related: Enhanced Recovery After Surgery (ERAS) Guidelines for Perioperative Care in Cardiac Surgery (guideline and commentary) AND Enhanced Recovery After Cardiac Surgery (ERAS Cardiac) Recommendations: An Important First Step—But There Is Much Work to Be Done – Cardiothoracic and Vascular Anesthesia (free)

See also: Enhanced Recovery After Surgery (ERAS) Society Guidelines

 

Commentary on Twitter

 


European position paper on the management of patients with patent foramen ovale. Part II – Decompression sickness, migraine, arterial deoxygenation syndromes, and select high-risk clinical conditions

18 Feb, 2021 | 02:36h | UTC

European position paper on the management of patients with patent foramen ovale. Part II – Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions – European Heart Journal

 


Observational study suggests aspirin is a better choice than warfarin for children who have undergone Fontan surgery

16 Feb, 2021 | 02:03h | UTC

Long-term outcomes of warfarin versus aspirin after Fontan surgery – The Journal of Thoracic and Cardiovascular Surgery

Commentary: Aspirin preferred to prevent blood clots in kids after heart surgery – Murdoch Children’s Research Institute

 

Commentary on Twitter

 


RCT: Dobutamine-sparing vs. dobutamine-to-all strategy in cardiac surgery

9 Feb, 2021 | 00:57h | UTC

Dobutamine-sparing versus dobutamine-to-all strategy in cardiac surgery: a randomized noninferiority trial – Annals of Intensive Care

 


Randomized trial: Conservative fluid management strategy vs. usual care in participants after cardiac surgery

1 Feb, 2021 | 01:39h | UTC

A Multicenter, Open-Label, Randomized Controlled Trial of a Conservative Fluid Management Strategy Compared With Usual Care in Participants After Cardiac Surgery: The Fluids After Bypass Study – Critical Care Medicine

 


Randomized trial: Continuous postoperative pericardial flushing reduces postoperative bleeding after coronary artery bypass grafting

29 Jan, 2021 | 01:28h | UTC

Continuous postoperative pericardial flushing reduces postoperative bleeding after coronary artery bypass grafting: A randomized trial – EClinicalMedicine

 


Meta-analysis: Minimally invasive surgery versus transcatheter aortic valve replacement

27 Jan, 2021 | 01:00h | UTC

Minimally invasive surgery versus transcatheter aortic valve replacement: a systematic review and meta-analysis – Open Heart

Commentary: TAVI vs Minimally Invasive AVR Yields Surprising Findings: Meta-analysis – TCTMD

 

Commentary on Twitter

 


Another study suggests fluoroquinolone use may increase the risk of development of aortic aneurysms

12 Jan, 2021 | 01:38h | UTC

Association of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm – JAMA Surgery (free for a limited period)

Commentaries: Fluoroquinolones and Aortic Disease—Is It Time to Broaden the Warning? – JAMA (free for a limited period) AND Study links fluoroquinolones to higher risk of aneurysm – CIDRAP AND Analysis Links Fluoroquinolones to Increased Aortic Aneurysm Risk – Physician’s Weekly

 


2020 ACC/AHA Guideline for the management of patients with valvular heart disease

18 Dec, 2020 | 09:45h | UTC

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines – Journal of the American College of Cardiology

News release: Updated guideline for heart valve disease spotlights less invasive treatments

Key Perspectives: Part 1

Key Perspectives: Part 2

Key Perspectives: Part 3

 

Commentary on Twitter

 


Review: Mechanical complications of acute myocardial infarction

11 Dec, 2020 | 09:19h | UTC

Mechanical Complications of Acute Myocardial Infarction: A Review – JAMA Cardiology

Videos: Acute Rupture of Left Ventricular Aneurysm AND Ventricular Septal Rupture AND Papillary Muscle Rupture

 


Review: Perioperative venous thromboembolism prophylaxis

3 Dec, 2020 | 08:28h | UTC

Perioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings

 


#AHA20 – Randomized trial: In patients with atrial fibrillation and a bioprosthetic mitral valve, Rivaroxaban (20 mg) was noninferior to Warfarin (INR 2-3) for death, MACE, or major bleeding at 12 months

16 Nov, 2020 | 02:01h | UTC

Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Rivaroxaban may be as effective as warfarin for bioprosthetic mitral valves, AF – American Heart Association

Commentaries: Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib – TCTMD AND Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation – RIVER – American College of Cardiology AND Rivaroxaban Noninferior to Warfarin for Atrial Fibrillation in Patients with Bioprosthetic Mitral Valves – NEJM Journal Watch

 

Commentary on Twitter

 


Safe surgery: A cluster randomized trial showed that the implementation of control charts with feedback on indicators to surgical teams was associated with concomitant reductions in major adverse events in patients

9 Nov, 2020 | 01:23h | UTC

Effect of monitoring surgical outcomes using control charts to reduce major adverse events in patients: cluster randomised trial – The BMJ

 


JACC Review: Evaluation and management of patients with stable angina. Based on large clinical trials, medical therapy rather than revascularization is the initial management strategy for most patients

6 Nov, 2020 | 09:43h | UTC

Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review – Journal of the American College of Cardiology (free for a limited period)

Summary: Evaluation and Management of Patients With Stable Angina – American College of Cardiology

 


Association between industry payments to physicians and device selection in ICD implantation

4 Nov, 2020 | 09:40h | UTC

Association Between Industry Payments to Physicians and Device Selection in ICD Implantation – JAMA (free for a limited period)

Editorial: Reconsidering Health Care Fraud and Abuse Laws (free for a limited period)

 

Commentary on Twitter

 


Review: Management of common postoperative complications

4 Nov, 2020 | 09:26h | UTC

Management of Common Postoperative Complications – Mayo Clinic Proceedings

 


The ‘Ten Commandments’ in the new ESC Adult Congenital Heart Disease Guidelines

29 Oct, 2020 | 08:59h | UTC

The ‘Ten Commandments’ in Adult Congenital Heart Disease Guidelines: From the 2020 European Society of Cardiology Guidelines for the Management of Adult Congenital Heart disease – European Heart Journal

Original guideline and commentaries: 2020 ESC Guidelines for the management of adult congenital heart disease

 


[Abstract Only] Redevelopment and validation of the SYNTAX score II to predict the benefit of PCI vs. CABG in patients with complex coronary artery disease

23 Oct, 2020 | 08:59h | UTC

Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation – The Lancet

See calculator: SYNTAX Score II calculator

 


Stay Updated in Your Specialty

No spam, just news.